Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0014 Transporter Info | ||||
Gene Name | ABCB11 | ||||
Transporter Name | Bile salt export pump | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg20118424) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:3.94E-06; Z-score:-1.18E+00 | ||
Methylation in Case |
6.35E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg08997639) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.55E+00 | Statistic Test | p-value:7.61E-13; Z-score:2.08E+00 | ||
Methylation in Case |
6.38E-01 (Median) | Methylation in Control | 4.12E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in hepatocellular carcinoma | [ 2 ] | |||
Location |
5'UTR (cg20118424) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:1.15E-02; Z-score:-1.10E+00 | ||
Methylation in Case |
5.05E-01 (Median) | Methylation in Control | 6.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in hepatocellular carcinoma | [ 2 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:5.16E-06; Z-score:-1.78E+00 | ||
Methylation in Case |
4.50E-01 (Median) | Methylation in Control | 5.68E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCB11 in hepatocellular carcinoma | [ 2 ] | |||
Location |
TSS200 (cg00295325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.45E+00 | Statistic Test | p-value:2.27E-05; Z-score:-1.71E+00 | ||
Methylation in Case |
2.98E-01 (Median) | Methylation in Control | 4.32E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of ABCB11 in hepatocellular carcinoma | [ 2 ] | |||
Location |
Body (cg24334048) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.08E-02; Z-score:-3.21E-01 | ||
Methylation in Case |
8.08E-01 (Median) | Methylation in Control | 8.28E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in bladder cancer | [ 3 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:4.64E-04; Z-score:-2.82E+00 | ||
Methylation in Case |
7.37E-01 (Median) | Methylation in Control | 8.13E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in bladder cancer | [ 3 ] | |||
Location |
TSS200 (cg00295325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:6.50E-04; Z-score:3.89E+00 | ||
Methylation in Case |
7.08E-01 (Median) | Methylation in Control | 6.26E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCB11 in bladder cancer | [ 3 ] | |||
Location |
Body (cg24334048) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.65E+00 | Statistic Test | p-value:1.41E-08; Z-score:-1.19E+01 | ||
Methylation in Case |
4.59E-01 (Median) | Methylation in Control | 7.59E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of ABCB11 in bladder cancer | [ 3 ] | |||
Location |
3'UTR (cg08997639) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:4.22E-02; Z-score:-9.56E-02 | ||
Methylation in Case |
8.88E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in breast cancer | [ 4 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:7.95E-03; Z-score:3.70E-01 | ||
Methylation in Case |
6.47E-01 (Median) | Methylation in Control | 6.14E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in breast cancer | [ 4 ] | |||
Location |
TSS200 (cg00295325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:8.05E-11; Z-score:1.61E+00 | ||
Methylation in Case |
6.01E-01 (Median) | Methylation in Control | 5.07E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:6.19E-05; Z-score:-1.12E+00 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in colorectal cancer | [ 5 ] | |||
Location |
TSS200 (cg00295325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.05E-02; Z-score:-3.98E-01 | ||
Methylation in Case |
8.20E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of ABCB11 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg24334048) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:5.26E-05; Z-score:-1.37E+00 | ||
Methylation in Case |
8.93E-01 (Median) | Methylation in Control | 9.21E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in depression | [ 6 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.32E-02; Z-score:-3.84E-01 | ||
Methylation in Case |
7.84E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.05E-02; Z-score:-1.15E+00 | ||
Methylation in Case |
8.60E-01 (Median) | Methylation in Control | 9.09E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in HIV infection | [ 7 ] | |||
Location |
Body (cg24334048) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:3.06E-02; Z-score:-4.50E-01 | ||
Methylation in Case |
8.61E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in panic disorder | [ 8 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.59E+00 | Statistic Test | p-value:1.88E-02; Z-score:4.76E-01 | ||
Methylation in Case |
5.24E-01 (Median) | Methylation in Control | 3.29E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in panic disorder | [ 8 ] | |||
Location |
3'UTR (cg08997639) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:1.16E-02; Z-score:6.15E-01 | ||
Methylation in Case |
2.96E+00 (Median) | Methylation in Control | 2.76E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg21346679) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.55E-02; Z-score:-1.96E-01 | ||
Methylation in Case |
7.91E-01 (Median) | Methylation in Control | 8.02E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of ABCB11 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg00295325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:4.17E-03; Z-score:9.36E-01 | ||
Methylation in Case |
7.76E-01 (Median) | Methylation in Control | 7.37E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg03371125) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:2.25E-02; Z-score:2.26E+00 | ||
Methylation in Case |
8.26E-01 (Median) | Methylation in Control | 7.17E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Significant hypermethylation of ABCB11 in prostate cancer than that in healthy individual | ||||
Studied Phenotype |
Prostate cancer [ICD-11:2C82] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.017051985; Fold-change:0.360333949; Z-score:1.26583558 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in systemic lupus erythematosus | [ 11 ] | |||
Location |
TSS200 (cg00295325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:4.16E-04; Z-score:-3.52E-01 | ||
Methylation in Case |
8.17E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of ABCB11 in pancretic ductal adenocarcinoma | [ 12 ] | |||
Location |
Body (cg04208466) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:1.54E-03; Z-score:-1.11E-01 | ||
Methylation in Case |
8.86E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Anaplastic pilocytic astrocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCB11 in anaplastic pilocytic astrocytoma than that in healthy individual | ||||
Studied Phenotype |
Anaplastic pilocytic astrocytoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:1.53E-10; Fold-change:-0.295597231; Z-score:-1.538932128 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Anaplastic pleomorphic xanthoastrocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCB11 in anaplastic pleomorphic xanthoastrocytoma than that in healthy individual | ||||
Studied Phenotype |
Anaplastic pleomorphic xanthoastrocytoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.019461089; Fold-change:-0.218761157; Z-score:-0.874356095 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Craniopharyngioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCB11 in craniopharyngioma than that in healthy individual | ||||
Studied Phenotype |
Craniopharyngioma [ICD-11:2F9A] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.003353029; Fold-change:-0.207730583; Z-score:-0.937268062 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Hemangioblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCB11 in hemangioblastoma than that in healthy individual | ||||
Studied Phenotype |
Hemangioblastoma [ICD-11:2F7C] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:1.03E-08; Fold-change:-0.241741058; Z-score:-2.090212325 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Melanocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCB11 in melanocytoma than that in healthy individual | ||||
Studied Phenotype |
Melanocytoma [ICD-11:2F36.2] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.011083397; Fold-change:-0.208858409; Z-score:-0.844106891 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Multilayered rosettes embryonal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCB11 in multilayered rosettes embryonal tumour than that in healthy individual | ||||
Studied Phenotype |
Multilayered rosettes embryonal tumour [ICD-11:2A00.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:1.26E-05; Fold-change:-0.276937013; Z-score:-1.254741734 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Prostate cancer metastasis |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypomethylation of ABCB11 in prostate cancer metastasis than that in healthy individual | ||||
Studied Phenotype |
Prostate cancer metastasis [ICD-11:2.00E+06] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.000275551; Fold-change:-0.279876166; Z-score:-20.97073859 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Brain neuroblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in brain neuroblastoma than that in healthy individual | ||||
Studied Phenotype |
Brain neuroblastoma [ICD-11:2A00.11] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:1.91E-09; Fold-change:-0.37456554; Z-score:-1.682525817 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Cerebellar liponeurocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in cerebellar liponeurocytoma than that in healthy individual | ||||
Studied Phenotype |
Cerebellar liponeurocytoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.003604809; Fold-change:-0.379516271; Z-score:-1.286820413 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Chordoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in chordoma than that in healthy individual | ||||
Studied Phenotype |
Chordoma [ICD-11:5A61.0] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:9.49E-05; Fold-change:-0.438917705; Z-score:-2.784598927 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Esthesioneuroblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in esthesioneuroblastoma than that in healthy individual | ||||
Studied Phenotype |
Esthesioneuroblastoma [ICD-11:2D50.1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:7.64E-17; Fold-change:-0.792196565; Z-score:-3.365760322 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Glioblastoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in glioblastoma than that in healthy individual | ||||
Studied Phenotype |
Glioblastoma [ICD-11:2A00.00] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:7.30E-10; Fold-change:-0.398486229; Z-score:-1.776461025 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:7.36E-18; Fold-change:-0.573845759; Z-score:-2.542306162 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Melanoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in melanoma than that in healthy individual | ||||
Studied Phenotype |
Melanoma [ICD-11:2C30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.001271; Fold-change:-0.302216161; Z-score:-1.265627539 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Peripheral neuroectodermal tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of ABCB11 in peripheral neuroectodermal tumour than that in healthy individual | ||||
Studied Phenotype |
Peripheral neuroectodermal tumour [ICD-11:2B52] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.28E-08; Fold-change:-0.431814822; Z-score:-2.037152809 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Gastric cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of ABCB11 in gastric cancer than that in adjacent tissue | ||||
Studied Phenotype |
Gastric cancer [ICD-11:2B72] | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue |
p-value:0.047579786; Fold-change:0.422342137; Z-score:2.145426985 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Histone acetylation |
|||||
Rat liver |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Hyperacetylation of Abcb11 in liver (compare with kidney and cerebrum cells) | [ 13 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Histone acetylation | Experiment Method | Chromatin immunoprecipitation | ||
Related Molecular Changes | Up regulation ofAbcb11 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Rat liver | ||||
Experimental Material |
Model organism in vivo (mouse) | ||||
Additional Notes |
The histone H3 associated with Oatp1b2 promoters was hyperacetylated in the liver but was acetylated very little in the kidney and cerebrum. | ||||
Histone methylation |
|||||
Cholestasis |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Histone methylation of ABCB11 in Cholestasis | [ 14 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Histone methylation | Experiment Method | . | ||
Related Molecular Changes | Down regulation ofABCB11 | Experiment Method | RT-qPCR | ||
Studied Phenotype |
Cholestasis[ ICD-11:5C50.1] | ||||
Experimental Material |
CBDL mice & HepG2 cells | ||||
Additional Notes |
MLL3 (as part of ASCOM complex) mediates H3K4me3 for FXR/GR-dependent activation of BSEP. Downregulated in cholestasis leading to reduced BSEP expression. | ||||
Hepatocellular carcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Histone methylation of ABCB11 in Hepatocellular carcinoma | [ 15 ] | |||
Location |
Promoter | ||||
Epigenetic Type |
Histone methylation | Experiment Method | . | ||
Related Molecular Changes | Down regulation ofABCB11 | Experiment Method | . | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12] | ||||
Experimental Material |
Ethanol-treated mice & HCC cells | ||||
Additional Notes |
Alcohol exposure upregulates histone methyltransferases (RBBP-5/Suv39h1/ASH2L/SET7/9) and downregulates demethylases (JARID1a/b/c), leading to BSEP suppression. Altered BA homeostasis promotes HCC progression. | ||||
microRNA |
|||||
Rat hepatocytes |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-33 downregulates ABCB11 expression | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Luciferase reporter assay | ||
Related Molecular Changes | Down regulation ofABCB11 | Experiment Method | RT-qPCR | ||
miRNA Stemloop ID |
miR-33 | miRNA Mature ID | Unclear | ||
miRNA Target Type |
Direct | ||||
Studied Phenotype |
Rat hepatocytes | ||||
Experimental Material |
Model organism in vivo (mouse); Human hepato cellular carcinoma cell line (HuH-7) | ||||
Additional Notes |
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity via downregulates of ABCB11 expression. | ||||
Unclear Phenotype |
16 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-1266 directly targets ABCB11 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1266 | miRNA Mature ID | miR-1266-3p | ||
miRNA Sequence |
CCCUGUUCUAUGCCCUGAGGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon2 |
miR-138-2 directly targets ABCB11 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-138-2 | miRNA Mature ID | miR-138-2-3p | ||
miRNA Sequence |
GCUAUUUCACGACACCAGGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon3 |
miR-1538 directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1538 | miRNA Mature ID | miR-1538 | ||
miRNA Sequence |
CGGCCCGGGCUGCUGCUGUUCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon4 |
miR-3074 directly targets ABCB11 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3074 | miRNA Mature ID | miR-3074-5p | ||
miRNA Sequence |
GUUCCUGCUGAACUGAGCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon5 |
miR-33a directly targets ABCB11 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Luciferase reporter assay//qRT-PCR | ||
miRNA Stemloop ID |
miR-33a | miRNA Mature ID | miR-33a-5p | ||
miRNA Sequence |
GUGCAUUGUAGUUGCAUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Model organism in vivo (mouse); Human hepato cellular carcinoma cell line (HuH-7) | ||||
Epigenetic Phenomenon6 |
miR-4307 directly targets ABCB11 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4307 | miRNA Mature ID | miR-4307 | ||
miRNA Sequence |
AAUGUUUUUUCCUGUUUCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon7 |
miR-4433a directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4433a | miRNA Mature ID | miR-4433a-3p | ||
miRNA Sequence |
ACAGGAGUGGGGGUGGGACAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon8 |
miR-4433b directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4433b | miRNA Mature ID | miR-4433b-3p | ||
miRNA Sequence |
CAGGAGUGGGGGGUGGGACGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon9 |
miR-449b directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-449b | miRNA Mature ID | miR-449b-3p | ||
miRNA Sequence |
CAGCCACAACUACCCUGCCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon10 |
miR-4700 directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4700 | miRNA Mature ID | miR-4700-3p | ||
miRNA Sequence |
CACAGGACUGACUCCUCACCCCAGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon11 |
miR-4745 directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4745 | miRNA Mature ID | miR-4745-3p | ||
miRNA Sequence |
UGGCCCGGCGACGUCUCACGGUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon12 |
miR-6504 directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6504 | miRNA Mature ID | miR-6504-3p | ||
miRNA Sequence |
CAUUACAGCACAGCCAUUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon13 |
miR-6720 directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6720 | miRNA Mature ID | miR-6720-3p | ||
miRNA Sequence |
CGCGCCUGCAGGAACUGGUAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon14 |
miR-6807 directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6807 | miRNA Mature ID | miR-6807-5p | ||
miRNA Sequence |
GUGAGCCAGUGGAAUGGAGAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon15 |
miR-7151 directly targets ABCB11 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7151 | miRNA Mature ID | miR-7151-3p | ||
miRNA Sequence |
CUACAGGCUGGAAUGGGCUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon16 |
miR-7152 directly targets ABCB11 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-7152 | miRNA Mature ID | miR-7152-5p | ||
miRNA Sequence |
UUUCCUGUCCUCCAACCAGACC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.